SCHEMBL401600

SCHEMBL401600

Cc1ccc(C(=O)OCc2ccccc2)c(Cl)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.62
TDP1 Q9NUW8 3/20 0.55
TSHR P16473 4/20 0.53
MAPK1 P28482 2/20 0.53
ALDH1A1 P00352 5/20 0.53
L3MBTL1 Q9Y468 5/20 0.51
RAB9A P51151 2/20 0.51
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
DHODH Q02127 2/20 0.49
EGLN1 Q9GZT9 1/20 0.49
CYP3A4 P08684 2/20 0.49
SLC6A2 P23975 1/20 0.49
SLC6A3 Q01959 1/20 0.49
KMT2A Q03164 1/20 0.49
EGFR P00533 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17700517 0.85 POLB (0.65) POLBTDP1TSHRMAPK1ALDH1A1
SCHEMBL20201203 0.85 ALDH1A1 (0.55) POLBTDP1TSHRMAPK1ALDH1A1
SCHEMBL17700715 0.83 POLB (0.59) POLBTDP1TSHRMAPK1ALDH1A1
SCHEMBL31414565 0.83 TSHR (0.53) POLBTDP1TSHRMAPK1ALDH1A1
SCHEMBL3583155 0.82 TSHR (0.52) TSHRALDH1A1KMT2AEGFRCYP1A2
SCHEMBL6647268 0.81 RAB9A (0.53) POLBTDP1TSHRMAPK1ALDH1A1
SCHEMBL4126156 0.79 POLB (0.53) POLBTSHRALDH1A1L3MBTL1RAB9A
SCHEMBL6645903 0.79 TSHR (0.52) POLBTDP1TSHRMAPK1ALDH1A1
SCHEMBL27032971 0.78 POLB (0.55) POLBTDP1TSHRMAPK1ALDH1A1
SCHEMBL6644878 0.78 TSHR (0.48) POLBTDP1TSHRMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
CN-101056628-B Ester derivatives and medicinal use thereof JAPAN TOBACCO INC 2011-05-25 CN disclosed
CN-101056628-A Ester derivatives and medicinal use thereof JAPAN TOBACCO INC (JP) 2007-10-17 CN disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed
US-20040133008-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-07-08 US disclosed
WO-2004039795-A2 AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133008-A1 Amide compounds APOB, APOL1, LDLR POLB 1209/4885TDP1 3247/4885TSHR 859/4885
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA POLB 3672/4885TDP1 582/4885TSHR 1411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.